Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer

被引：0
|
作者：
Imai, H. [1 ]
Minemura, H. [2 ]
Moriya, H. [3 ]
Sugiyama, T. [4 ]
Yamada, Y. [5 ]
Higuchi, M. [6 ]
Kaira, K. [7 ]
Ozaki, Y. [8 ]
Kanazawa, K. [2 ]
Yokouchi, H. [9 ]
Kasai, T. [4 ]
Kaburagi, T. [5 ]
Suzuki, H. [8 ]
Minato, K. [1 ]
Shibata, Y. [2 ]
机构：
[1] Gunma Prefectural Canc Ctr, Div Resp Med, Ota, Gunma, Japan
[2] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
[3] Ohara Gen Hosp, Diagnost Imaging Ctr, Fukushima, Japan
[4] Tochigi Canc Ctr, Div Thorac Oncol, Utsunomiya, Tochigi, Japan
[5] Ibaraki Prefctural Cent Hosp & Canc Ctr, Resp Med, Ibaraki, Japan
[6] Fukushima Med Univ, Dept Surg, Aizu Med Ctr, Fukushima, Japan
[7] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Saitama, Japan
[8] Fukushima Med Univ, Sch Med, Dept Chest Surg, Fukushima, Japan
[9] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
non-small cell lung cancer; immune check point inhibitor; Morphologic characteristics;
D O I：
10.1016/j.jtho.2018.08.1603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-43
引用
收藏
页码：S883 / S884
页数：2
相关论文
共 50 条
  • [21] Evaluating inflammatory markers as predictive tools for advanced non-small cell lung cancer receiving nivolumab Predictive markers for nivolumab response in advanced NSCLC
    Karaboyun, Kubilay
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 361 - 365
  • [22] Angiogenesis in Non-small Cell Lung Cancer Imaging With Perfusion Computed Tomography
    Ng, Quan Sing
    Goh, Vicky
    JOURNAL OF THORACIC IMAGING, 2010, 25 (02) : 142 - 150
  • [23] Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases
    Akano, Yumiko
    Kuribayashi, Kozo
    Funaguchi, Norihiko
    Koda, Yuichi
    Fujimoto, Eriko
    Mikami, Koji
    Minami, Toshiyuki
    Takahashi, Ryo
    Yokoi, Takashi
    Kijima, Takashi
    IN VIVO, 2019, 33 (02): : 507 - 514
  • [24] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [25] Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer
    Lee, Ho Yun
    Lee, Hyun Ju
    Kim, Young Tae
    Kang, Chang Hyun
    Jang, Bo Gun
    Chung, Doo Hyun
    Goo, Jin Mo
    Park, Chang Min
    Lee, Chang Hyun
    Kang, Keon Wook
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) : 497 - 503
  • [26] Duration of nivolumab for pretreated, advanced non-small-cell lung cancer
    Geier, Margaux
    Descourt, Renaud
    Corre, Romain
    Leveiller, Guillaume
    Lamy, Regine
    Goarant, Eric
    Bizec, Jean-Louis
    Bernier, Cyril
    Quere, Gilles
    Amrane, Karim
    Gaye, Elisabeth
    Lucia, Francois
    Burte, Emilie
    Chouaid, Christos
    Robinet, Gilles
    CANCER MEDICINE, 2020, 9 (19): : 6923 - 6932
  • [27] Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
    Svaton, Martin
    Zemanova, Milada
    Skrickova, Jana
    Jakubikova, Lenka
    Kolek, Vitezslav
    Kultan, Juraj
    Koubkova, Leona
    Bejckova, Alzbeta
    Salajka, Frantisek
    Hrnciarik, Michal
    Melichar, Bohuslav
    Vrana, David
    Konecny, Marek
    Chloupkova, Renata
    Pesek, Milos
    ANTICANCER RESEARCH, 2018, 38 (12) : 6771 - 6782
  • [28] Chronic Inflammation as Potential Predictive Factor of Nivolumab Therapy in Non-Small Cell Lung Cancer
    Svaton, M.
    Zemanova, M.
    Skrickova, J.
    Kolek, V.
    Koubkova, L.
    Salajka, F.
    Melichar, B.
    Pesek, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S978 - S979
  • [29] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Tisserand, Julie
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Leprieur, Etienne Giroux
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [30] Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer
    Maekura, Toshiya
    Naito, Maiko
    Tahara, Masahiro
    Ikegami, Naoya
    Kimura, Yohei
    Sonobe, Shoko
    Kobayashi, Takehiko
    Tsuji, Taisuke
    Minomo, Shojiro
    Tamiya, Akihiro
    Atagi, Shinji
    IN VIVO, 2017, 31 (05): : 1035 - 1039
12345